Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/QNTM stock hub

CSE/QNTM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/QNTMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

39.1M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/QNTM

In the news

Latest news · CSE/QNTM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-2,056.5

P25 -121.5P50 -40.9P75 0.5

ROIC-353.4

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/QNTM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

141

Groups with data

Currency

USD

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	17
Employees Change	7%
Employees Change Percent	70
Enterprise value	CAD 31.1M
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	CAD 39.1M
Price	CAD 6.7
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/QNTM
Website	https://www.quantumbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-111.36%
EV Earnings	-0.71x
P/B ratio	-19.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -43.5M
Profit Per Employee	CAD -2.6M
ROA	-62.38
Roa5y	-48.6
ROCE	1,047.3
ROE	-2,056.5
Roe5y	-139.3
ROIC	-353.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-41.86%
Cagr3y	-61.08%
Cagr5y	-45.01%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 20.8M
Cash	CAD 6.4M
Current Assets	CAD 14.2M
Current Liabilities	CAD 22.3M
Debt	CAD 1.2M
Equity	CAD -2M
Interest Coverage	-6.81
Liabilities	CAD 22.8M
Long Term Assets	CAD 6.7M
Long Term Liabilities	CAD 470,927
Net Cash	CAD 5.2M
Net Cash By Market Cap	CAD 13.21
Net Cash Growth	63.56%
Tangible Book Value	CAD -5.3M
Tangible Book Value Per Share	CAD -1.19
WACC	12.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.63
Net Working Capital	CAD -13.5M
Quick ratio	0.29
Working Capital	CAD -8.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-136.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-41.84%
200-day SMA	14.32
3Y total return	-94.11%
50-day SMA	5.17
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.97%
All Time High	12,281.2
All Time High Change	-99.95%
All Time High Date	2018-09-20
All Time Low	2.85
All Time Low Change	135.09%
All Time Low Date	2026-03-11
ATR	0.74
Beta	0.36
Beta1y	4.75
Beta2y	3.06
Ch YTD	-36.19
High	6.84
High52	52
High52 Date	2025-06-20
High52ch	-87.12%
Low	6.65
Low52	2.85
Low52 Date	2026-03-11
Low52ch	135.09%
Ma50ch	29.49%
Price vs 200-day SMA	-53.21%
RSI	56.34
RSI Monthly	39.05
RSI Weekly	44.57
Sharpe ratio	0.46x
Sortino ratio	0.81
Total Return	-136.38%
Tr YTD	-36.19
Tr1m	25%
Tr1w	-11.61%
Tr3m	17.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -20.8M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,362,502%
Net Borrowing	4,605,484.8
Shares Insiders	8.01%
Shares Institutions	10.46%
Shares Out	5,829,265
Shares Qo Q	17.16%
Shares Yo Y	136.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	10,368.8x
Bv Per Share	0.19
Ch1m	25
Ch1w	-11.61
Ch1y	-41.84
Ch3m	17.54
Ch3y	-94.11
Ch5y	-94.97
Ch6m	-46.4
Change	-3.74%
Change From Open	0
Close	6.96
Days Gap	-3.74
Depreciation Amortization	743,027.2
Dollar Volume	66,001.7
Earnings Date	2026-05-14
EBIT	CAD -20.8M
EBITDA	CAD -20M
EPS	CAD -11.48
F Score	1
Financing CF	13,908,395
Fiscal Year End	December
Founded	1,998
Investing CF	-4,879,257
Is Primary Listing	1
Last Earnings Date	2026-03-24
Last Report Date	2026-03-31
Last Split Date	2024-08-15
Last Split Type	Reverse
Ma150	9.96
Ma150ch	-32.74%
Ma20	5.82
Ma20ch	15.2%
Net CF	1,149,623
Next Earnings Date	2026-05-14
Open	6.7
Position In Range	26.32
Ppne	201,690.5
Price Date	2026-05-08
Relative Volume	0.95x
Share Based Comp	4,950,120
Tr6m	-46.4%
Volume	9,851

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/QNTM pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/QNTM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/QNTM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.5%

Share of float held by funds and institutions

Insider ownership

+8.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+136.4%

Negative means the company is buying back shares.

Technical

CSE/QNTM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.3

Neutral momentum band

Price vs 200-day MA

-53.2%

50/200-day relationship not available

Beta (5Y)

0.36

Less volatile than the market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/QNTM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/QNTM stock rating?

cse/QNTM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/QNTM analysis?

The full report lives at /stocks/cse/QNTM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/QNTM?

The latest report frames cse/QNTM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/QNTM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.